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Abstract The ubiquitously expressed Na+/H+ exchanger
(NHE1) plays an important role in the regulation of the
intracellular pH. Induction of NHE activity by phorbol esters
and inhibition of growth factor-mediated stimulation of the NHE
by protein kinase C (PKC) inhibitors suggest an implication of
PKCs in the regulation of the NHE. Expression of PKC isotype-
specific dominant negative and constitutively active mutants or
downregulation of PKC by isotype-specific antisense oligonu-
cleotides revealed that stimulation by epidermal growth factor
(EGF) or phorbol ester of the NHE in NIH3T3 cells is a PKCK-
specific effect. Elevation of cytoplasmic calcium by a Ca2+
ionophore or thapsigargin causes a growth factor-independent
stimulation of the NHE predominantly mediated by calcium/
calmodulin kinase II. It is concluded that in NIH3T3 cells
overexpressing the EGF receptor (EGFR6 cells), EGF requires
cPKCK for the activation of the NHE, while calcium/calmodulin-
dependent kinases are essential in thapsigargin induced stimula-
tion of the NHE. 0 2002 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
Naþ/Hþ exchangers (NHE) are important regulators of cy-
toplasmic pH. Up to now, six isoforms (NHE1^NHE6) have
been identi¢ed [1,2]. The NHE1 isoform [3] is ubiquitously
expressed in mammalians and is characterized by high ami-
loride sensitivity, 12 transmembrane domains and the cyto-
plasmic carboxy-terminus for interaction with several intra-
cellular regulators such as calcium, calcium/calmodulin or
protein kinases. Activation of the NHE by extracellular sig-
nalling is associated with phosphorylation of serine residues
suggesting a kinase-dependent regulation. Although it has
been demonstrated that phorbol esters (TPA) increase the
phosphorylation of the NHE1 in ¢broblasts [4], mutation of
a protein kinase C (PKC) consensus phosphorylation site [5]
did not attenuate the TPA-induced activation of the NHE1
arguing against a direct PKC-mediated phosphorylation. Nu-
merous observations, however, emphasize a crucial role of
PKCs in regulation of the NHE. Inhibitors of PKC like stau-
rosporine or PKC depletion by long-term treatment with
phorbol esters prevent the activation of the NHE [6,7]. Induc-
tion of PKC activity by diacylglycerol or short-term exposure
to TPA leads to activation of the NHE [8]. These results
indicate an implication of classical or novel PKC isoforms
in the regulation of the NHE. Direct evidence for this sugges-
tion and characterization of the corresponding PKC isozyme,
however, have not been presented.
In epidermal growth factor receptor-6 (EGFR6) cells it has
been demonstrated that stimulation of the EGF receptor by
its ligand leads to an activation of the mitogen-activated pro-
tein (MAP) kinase pathway [9,10]. The Ras-Raf1-MEK sig-
nalling pathway was shown to be crucial for the activation of
the growth factor- and Ras-dependent stimulation of the
NHE1 in CCL39 ¢broblasts [11,12]. These ¢ndings strongly
suggest that an implication of this pathway in regulation of
the NHE in EGFR6 cells has to be considered.
Increase in cytoplasmic calcium concentration has been
demonstrated to stimulate sodium in£ux by activation of the
NHE [13]. Application of calcium ionophores immediately
activates the NHE1 [5]. Calcium could lead to an activation
of calcium-dependent kinases like PKC and calcium/calmod-
ulin-dependent protein kinases or promote the binding of cal-
modulin to high-a⁄nity binding sites of the NHE [14]. The
activation of classical PKCK is known to be calcium-depen-
dent [15]. It is conceivable, therefore, that a member of the
classical PKC subfamily acts as a putative regulator of NHE.
EGFR6 cells express the PKC isotypes K, O, V and j.
In order to address the question which PKC isotypes are
involved in the regulation of the NHE, representatives from
each of the three major sub-families of PKC, i.e. classical
(cPKC), novel (nPKC) and atypical (aPKC) were investigated.
Dominant negative and constitutively active mutants of each
of these PKC isotypes were employed to elucidate the impli-
cation of the PKC by transient transfection of EGFR6 cells.
In addition, PKC antisense oligonucleotides (PKCK and
PKCO) were used to downregulate the expression of these
proteins. Embryonic ¢broblasts derived from a PKCK3/3
‘knock-out’ mouse were employed to substantiate the results
obtained by the transfection assays. The role of calcium in the
regulation of the NHE was studied either by reducing the
cytoplasmic free calcium by the calcium chelators BAPTA
and EGTA or by increasing the cytoplasmic calcium concen-
tration by A23187 and thapsigargin. The role of calcium/cal-
modulin-dependent protein kinases was studied by application
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of the inhibitor KN-93. The possible implication of the MAP
kinase pathway in regulation of the NHE was investigated by
employing the MAP kinase inhibitor PD-98059 and transient
transfection of a constitutively active MEK.
The studies revealed that in EGFR6 cells stimulation by
EGF leads to a cPKCK-dependent activation of the NHE
and that the calcium-dependent activation of cPKCK is su⁄-
cient for the stimulation of the NHE. Neither novel nPKCO
and atypical PKCV nor Erk1/2 are implicated in the EGF-
mediated activation of the NHE in this cell system while cal-
cium/calmodulin-dependent kinases are critical in thapsigar-
gin-induced stimulation of the NHE.
2. Materials and methods
2.1. Materials
EGF, ATP, TPA, EGTA, A23187, EIPA, thapsigargin, nigericin,
aprotinin and leupeptin were obtained from Sigma (Vienna, Austria)
and BCECF-AM and BAPTA-AM from Molecular Probes Europe
(Leiden, The Netherlands). Cell culture media were purchased from
Bender (Vienna, Austria), Opti-Mem I medium from Life Technolo-
gies (Vienna, Austria) and the TransFast1 transfection reagent from
Promega (Mannheim, Germany). Monoclonal anti-NHE1 antibody
was obtained from Chemicon (Biomedica, Vienna, Austria) and poly-
clonal rabbit anti-PKCK, PKCO, PKCV and PKCj antibodies from
Santa Cruz Biotechnology (Heidelberg, Germany). Tachisorb was
purchased from Calbiochem (Lucerne, Switzerland).
2.2. Cell culture
NIH3T3 ¢broblasts overexpressing EGFR (EGFR6), [9] were
grown in Dulbecco’s modi¢ed Eagle’s medium, supplemented with
10% fetal calf serum (FCS) and 2 mM L-glutamine at 37‡C in a
humidi¢ed atmosphere (95% air, 5% CO2).
2.3. Production of PKCK knock-outs and controls
Production of PKCK-de¢cient (PKCK3/3) mice and genotypic de-
termination were performed as will be described elsewhere (manu-
script in preparation). In brief, PKCK knock-outs were generated
using the standard techniques of the gene targeting approach. To
generate a PKCK3/3 mouse line the 129/SV strain was used for
the backcross. F2 homozygotes and 129/SV wild type (wt) were
used for the generation of PKCK3/3 embryonic ¢broblast cells
(EMFI) using standard protocols [18].
2.4. Plasmids, oligonucleotides and transfection protocols
The generation of dominant negative (DN) PKC mutants (KK=R,
OK=R, jK=R, VK=W) and constitutively active (CA) PKC mutants (KA=E,
OA=E, jA=E, VA=E) has been described previously [16,17]. PKCK sense
(ATGGCTGACGTTTACCCG), PKCK antisense (CGGGTAAA-
CGTCAGCCAT), PKCO sense (AGGTCACATCAGCCCTCATG)
and PKCO antisense (CATGAGGGCTGATGTGACCT) oligonucleo-
tides were synthesized by Microsynth (Balgach, Switzerland). NIH3T3
cells (EGFR6) were seeded in 10 cm wells containing circular glass
coverslips. Transfection of subcon£uent monolayers with the indi-
cated expression vectors (all subcloned into the expression vector
pEF1-neo) or oligonucleotides was carried out with Transfast1 as
described by the manufacturer.
2.5. Western blot analysis
Western blot analysis of NHE1 and PKC isotypes was performed
as described previously [16].
2.6. NHE activity and pHi
The cells were grown on round glass coverslips (22 mm). One day
after plating the cells were kept in low serum medium (0.5% FCS) for
36^48 h for serum starvation. At this time point average cell count per
coverslip was approximately 0.5U105 cells. pHi (intracellular pH) was
determined by £uorescence spectrophotometry employing BCECF
(2P,7P-biscarboxyethyl-5(6)-carboxy£uorescein). Cells attached to cov-
erslips were washed in HCO3-free HEPES-bu¡ered saline (HBS)
(140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 5.5 mM
glucose, 20 mM HEPES/NaOH, pH 7.4). The cells were loaded with
BCECF by incubation in HBS containing 1 WM BCECF acetoxy
methyl ester for 10 min at 37‡C and subsequent washing (two times)
with HBS. Fluorescence (excitation, 502 or 440 nm; emission, 530 nm)
was measured with a single cell imaging system (Applied Imaging,
Sunderland, UK). The cytoplasmic pHi values were calculated from
the ratio of the £uorescence intensities I502/I440. The ratio of the £uo-
rescence intensities I502/I440 was calibrated to pHi using a nigericin
calibration procedure as described [6]. The NHE activity was deter-
mined by measuring the cytoplasmic pHi after acidi¢cation by a
NH4Cl preloading technique [11]. The recovery of pHi from acid
load (vpHi/vt) was determined from the slope of the pHi tracing.
3. Results
3.1. Expression patterns of NHE1 and PKC isozymes in
EGFR6 and EMFI cells
The expression levels of NHE1 were analyzed in EGFR6
cells [10] and in EMFI cells (wt or PKCK3/3) by Western
blot analysis (Fig. 1a). As shown in Fig. 1b, EGFR6 cells
express the PKC isozymes cPKCK, nPKCO and aPKCV/j.
In vivo expression and biological activities of DN (K/R and
K/W) or CA mutants (A/E) of the various PKC isoforms have
been described previously [16]. According to expectations and
in contrast to the corresponding wt EMFIs, cPKCK was not
detectable in the PKCK3/3 cell line (Fig. 1c).
3.2. Activation of the NHE1
The NHE activity was determined by measuring the cyto-
plasmic pHi after acidi¢cation by NH4Cl employing a single
cell imaging technique. The basal activity of the NHE after
2 days of serum starvation and a de¢ned acid load procedure
by applying the NH4Cl preloading technique was comparable
in all cell lines (1.06R 0.15U1033 vpHi/s). The NHE activity
could be increased by stimulation of the EGFR6 cells with
either EGF or ATP, the latter acting via R7G receptors as
shown in Fig. 2. Typically for the NHE1 isoform, the activity
was completely inhibited by preincubation with 100 WM of the
Fig. 1. Expression patterns of NHE1 and PKC isozymes in
NIH3T3 (EGFR6) and EMFI cells. Western blot analysis of (a) the
NHE subtype NHE1 in EGFR6 and EMFI (wt and PKCK3/3),
(b) the PKC isotypes in EGFR6 cells and (c) the PKC isotypes K
and O in EMFI.
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amiloride analogue EIPA. The activation of the NHE by stim-
ulation of PKC with TPA in this cell system is demonstrated.
The EGF- and TPA-induced activation of the NHE was sup-
pressed by the PKC inhibitor GF109303X or depletion of
PKC after long-term treatment (24 h) with phorbol ester. In
contrast to EGFR6, in PKCK3/3 EMFI cells, the NHE
could be activated neither by TPA nor by ATP. This result
points to a critical role of the PKC isoforms PKCK or/and
PKCO in the regulation of the NHE.
As described previously [9,10] stimulation of EGFR6 cells
by EGF causes an increase in inositol phosphate and diacyl-
glycerol formation followed by an increase of the cytoplasmic
calcium concentration, possibly leading to an activation of
PKC. Taken together these results indicate an implication of
PKCs in the EGF-mediated pathway of the NHE activation.
Therefore, the role of classical, novel and atypical PKC iso-
zymes in regulation of the NHE1 was investigated in more
detail.
3.3. Role of di¡erent PKC isozymes in activation of the NHE
Transient transfection of EGFR6 cells with PKCKK=R and
nPKCOK=R caused an almost complete inhibition of the EGF-
induced activation of the NHE (Fig. 3) and a signi¢cant sup-
pression of the TPA-mediated stimulation. The activation of
the NHE, however, was not a¡ected by expression of
PKCjK=W. This result strongly suggests an implication of
cPKCK and nPKCO in the activation of the NHE. These
suppositions were checked by antisense constructs. Transfec-
tion of EGFR6 cells with PKCK antisense oligonucleotides
reduced the expression of cPKCK in a dose-dependent manner
(Fig. 4a). The same result was obtained by PKCO antisense
oligonucleotides depleting PKCO in this cell system (Fig. 4b).
PKCK antisense oligonucleotides at a concentration of 3 WM
were able to inhibit the TPA- and EGF-induced activation of
the NHE, comparable to PKCKK=R (Fig. 4c). In contrast to
nPKCOK=R, the PKCO antisense construct did not a¡ect the
EGF-induced activation of the NHE (Fig. 4d). PKCKA=E but
not PKCOA=E provoked a weak but signi¢cant activation of
the NHE (Fig. 4e).
3.4. Calcium-dependent activation of the NHE
Stimulation of EGFR6 cells by EGF causes an increase of
the cytoplasmic calcium concentration by release of calcium
from intracellular stores followed by a store depletion-acti-
vated calcium in£ux as demonstrated previously [9]. Binding
of intracellular free calcium by BAPTA and simultaneous re-
moval of the extracellular calcium by EGTA inhibits the
EGF- and TPA-induced activation of the NHE (Fig. 5a).
Elevation of cytoplasmic calcium by thapsigargin or the cal-
cium ionophore A23187 leads to a growth factor-independent
activation of the NHE (Fig. 5b). To test whether the calcium-
induced stimulation of the NHE is cPKC-dependent, thapsi-
gargin- and A23187-mediated activation of the NHE was car-
ried out in EGFR6 cells expressing PKCKK=R. The kinase-
defective PKCKK=R partially reduced the calcium-induced ac-
Fig. 2. Activation of the NHE. The NHE activity of EGFR6 cells
was determined by measuring the time-dependent recovery of the
cytoplasmic pHi after acidi¢cation by NH4Cl employing a single
cell imaging technique as described in Section 2. After 2 days of se-
rum starvation induction by 0.1 WM EGF and 1 WM ATP (5 min)
revealed a threefold increase of the activity which could be blocked
by the NHE inhibitor EIPA. The phorbol ester (0.1 WM TPA,
5 min) and EGF-induced activation of the NHE is depressed by the
PKC inhibitor GF109303X and after depletion of PKC by long-
term treatment with TPA (24 h). Bars represent meanRS.E.M.
(nv 10). In wt EMFI cells the NHE is activated by 0.1 WM TPA
and 1 WM ATP. EMFI cells derived from a corresponding PKCK3/
3 knock-out mouse revealed no signi¢cant stimulation of the NHE
by TPA or ATP. Bars represent meanRS.E.M. (nv 6).
Fig. 3. Role of representatives from each of the three major sub-
families of the PKC isotypes in EGF- and TPA-induced activation
of the NHE. EGFR6 cells were transfected with kinase-defective
PKCKK=R, nPKCOK=R or vector control pEF-neo (mock) together
with the reporter plasmid GFP as a selection marker. Inhibition of
the EGF-induced NHE activity was seen after expression of both
DN isotypes K and O. Essentially the same result was obtained after
stimulation of the NHE by TPA. Expression of the DN isoform of
aPKCj failed to inhibit the EGF-mediated activation of the NHE.
Bars represent meanRS.E.M. (nv 10).
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tivation of the NHE. The thapsigargin-induced activation of
the NHE, however, was almost completely inhibited by the
calcium/calmodulin II kinase inhibitor KN-93 (Fig. 5c). It is
concluded, that the stimulation of the NHE by calcium results
from activation of calcium-dependent kinases like cPKCK and
calcium/calmodulin kinases.
3.5. Erk-independent activation of the NHE
In EGFR6 cells it has been demonstrated that stimulation
of the EGF receptor by EGF leads to an activation of the
MAP kinase pathway [9,10]. The Ras-Raf1-MEK signalling
pathway was shown to be essential for the activation of the
Ras-dependent stimulation of the NHE1 in CCL39 ¢broblasts
[11]. Moreover, in this cell system, the growth factor-induced
activation of the MAP kinase cascade plays a predominant
role in NHE1 stimulation [12]. It was, therefore, decided to
investigate whether stimulation of the MAP kinase pathway
by EGF leads to an activation of the NHE in EGFR6 cells.
Fig. 4. Depletion of PKCK and PKCO by antisense oligonucleotides. EGFR6 cells were incubated with increasing concentrations of antisense
oligonucleotides as indicated. The concentration-dependent depletion of PKCK (a) and PKCO (b) by the antisense oligonucleotides but not by
the corresponding sense oligonucleotides is demonstrated. The EGF- and TPA-induced activation of the NHE is inhibited by depletion of
PKCK (c) but una¡ected after depletion of PKCO (d). The basal activity of the NHE is increased by overexpression of PKCKA=E but not of
PKCOA=E (e). Bars represent meanRS.E.M. (nv 10).
Fig. 5. Calcium-dependent activation of the NHE. Removing of cytoplasmic free calcium by BAPTA/EGTA reduces the basic activity of the
NHE and inhibits the EGF- and TPA-induced stimulation of the NHE (a). Increase of cytoplasmic calcium by addition of 1 Wg/ml A23187
and 1 WM thapsigargin leads to a growth factor-independent activation of the NHE and transfection of PKCKK=R attenuates the A23187- and
thapsigargin-induced activation of the NHE (b). Inhibition of calcium/calmodulin kinase II by KN-93 (10 WM for 18 h) represses the basal and
the thapsigargin-induced activation of the NHE, while the EGF-mediated stimulation of the NHE remains una¡ected (c). Bars represent
meanRS.E.M. (nv 10).
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Employing the MEK inhibitor PD-98059, however, revealed
no signi¢cant attenuation of the EGF-induced activation of
the NHE. Furthermore, overexpression of a constitutively ac-
tive MEK failed to activate the NHE in the absence of EGF
(Fig. 6). These data indicate that the MEKsERK cascade is
not involved in the EGF-mediated activation of the NHE.
4. Discussion
NIH3T3 cells overexpressing the EGF receptor (EGFR6
cells) contain the PKC isotypes cPKCK, nPKCO, aPKCV
and aPKCj. The data presented here demonstrate that the
growth factor-induced activation of the ubiquitously ex-
pressed isoform of the NHE, NHE1, selectively requires
cPKCK. This conclusion is based on the observations that
(i) downregulation of PKC by long-term exposure to TPA,
(ii) expression of kinase-defective PKCKK=R, and (iii) deple-
tion of cPKCK by isotype-speci¢c antisense oligonucleotides
lead to an almost complete inhibition of the phorbol ester-
and the EGF-induced stimulation of the NHE. (iv) Final
proof of this concept came from experiments employing
PKCK3/3 embryonic ¢broblasts derived from the PKCK3/
3 knock-out mouse. Compared to the corresponding wt cell
line, these cells expressed about the same level of NHE1 and
nPKCO, but no detectable amount of cPKCK as shown in Fig.
1d. Whereas in the wt cell line the stimulation by TPA and
ATP induced a signi¢cant activation of the NHE similar to
EGFR6 cells, this was not the case in the corresponding
PKCK3/3 cells (Fig. 2).
Both isotypes of PKC, cPKCK and nPKCO, are activated
by diacylglycerol or the widely used more active surrogate
TPA. Stimulation of the EGFR6 cells by EGF leads to an
activation of PLCQ [10] and thereby to formation of diacyl-
glycerol and inositol 4,5-bisphosphate which in turn cause an
increase in cytoplasmic calcium [9]. Consequently, this signal-
ling cascade induced by EGF could activate cPKCK as well as
nPKCO. If PKCO were implicated in the regulation of the
NHE, it would be expected that expression of nPKCOK=R
causes an inhibition of the EGF- or TPA-induced activation
of the NHE. As demonstrated in Fig. 3, this was indeed the
case. Depletion of nPKCO, however, failed to inhibit the
EGF-induced activation of the NHE (Fig. 4b,d). Thus, an
expression of DN PKCO somehow interferes with endogenous
PKCK, perhaps by competition with a joint cofactor like di-
acylglycerol. Expression of DN, kinase-de¢cient mutants of
PKCK and PKCO is, therefore, not su⁄cient to unambigu-
ously de¢ne a PKC dependence in this system. The failure
of PKCO-depleted cells to inhibit the EGF-induced activation
of the NHE clearly indicates the operation of a PKCO-inde-
pendent pathway. This conclusion is furthermore supported
by the ¢nding that removal of cytoplasmic free calcium by
BAPTA blocked the EGF-induced stimulation of the NHE
(Fig. 5a), although the activation of nPKCO is known to be
calcium-independent, due to the lack of the calcium binding
site C2 of the regulatory domain. Furthermore, in PKCK3/3
cells which express a normal level of nPKCO (Fig. 1c) no
signi¢cant activation of the NHE by TPA and ATP could
be observed (Fig. 2). Collectively these ¢ndings indicate that
nPKCO is not implicated in the PKC-dependent regulation of
the NHE.
The MAP kinase pathway is considered essential in growth
factor-stimulated activation of the NHE1 in CCL39 cells [12].
Members of aPKCs have been described previously as crucial
downstream targets and regulators in the Ras-MAP kinase
pathway in epithelial cells [16]. Therefore, it was attractive
to study the implication of the MAP kinase cascade in regu-
lation of the NHE. However, in contrast to CCL39 cells,
blockade of this pathway by a MAP kinase inhibitor failed
to attenuate the EGF-induced activation of the NHE in
EGFR6 cells and overexpression of constitutively active
MEK was insu⁄cient to activate the NHE growth factor in-
dependently (Fig. 6). Finally, DN isotypes of PKCV and
PKCj did not a¡ect the EGF-mediated stimulation of the
NHE.
In addition to PKCK, the concentration of cytoplasmic free
calcium is critical for the regulation of the NHE in EGFR6
cells. Removing the cytoplasmic calcium by BAPTA/EGTA
leads to a reduction of the basal activity of the NHE (Fig. 5a)
and the EGF-induced pathway is completely inhibited under
these conditions. Elevation of cytoplasmic calcium by thapsi-
gargin and A23187 was able to mimic a growth factor-inde-
pendent stimulation of the NHE which could only in part be
inhibited by DN PKCKK=R (Fig. 5b). These ¢ndings support a
model in which the thapsigargin- and A23187-induced stimu-
lation of the NHE is mediated in part by a calcium-mediated
activation of the calcium-dependent PKCK, but to a greater
extent by another, PKC-independent mechanism [14]. Indeed,
a strong inhibition of the thapsigargin-induced activation of
the NHE was observed by application of the calcium/calmod-
ulin kinase II inhibitor KN-93 (Fig. 5c), indicating a predom-
inant role of the calmodulin kinase II in the calcium-induced
stimulation of the NHE. In view of the poor inhibition by
KN-93 of the EGF-induced activation of the NHE it must be
concluded that the EGF-induced stimulation of the NHE is
predominantly mediated by PKCK and not by a KN-93-sen-
sitive kinase.
In summary, the data presented here clearly demonstrate
that among the PKC isotypes expressed in our cell systems,
only PKCK is implicated in the EGF- and TPA-induced acti-
vation of the NHE in EGFR6 cells. Surprisingly, no contri-
bution to the activation of the NHE by the MAP kinase
cascade, which has been shown to be important in CCL39
cells [12], could be demonstrated in this cell system. High
levels of cytosolic free calcium are also su⁄cient to stimulate
the NHE via calcium/calmodulin kinase II. Full activation of
Fig. 6. The EGF-stimulated activation of the NHE is not a¡ected
by the MAP kinase pathway. Preincubation of the cells with the
MAP kinase inhibitor PD-98059 (50 WM) for 18 h shows no signi¢-
cant e¡ect on the EGF-stimulated activation of the NHE and over-
expression of a constitutively active form of MAP kinase (caMEK)
is ine¡ective to stimulate the NHE in the absence of EGF. Bars
represent meanRS.E.M. (nv 8).
FEBS 26186 7-6-02
K. Maly et al./FEBS Letters 521 (2002) 205^210 209
the NHE by EGF, however, depends on the combined e¡ects
of active PKCK and calcium.
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